747 related articles for article (PubMed ID: 24457024)
1. Perilous journey: a tour of the ubiquitin-proteasome system.
Kleiger G; Mayor T
Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-Proteasome Pathway and Muscle Atrophy.
Khalil R
Adv Exp Med Biol; 2018; 1088():235-248. PubMed ID: 30390254
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin proteasome system in immune regulation and therapeutics.
Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
[TBL] [Abstract][Full Text] [Related]
4. A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.
Hughes DC; Goodman CA; Baehr LM; Gregorevic P; Bodine SC
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1567-C1582. PubMed ID: 37955121
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the stress-responsive enzyme formate dehydrogenase by the RING-type E3 ligase Keep on Going and the ubiquitin 26S proteasome system.
McNeilly D; Schofield A; Stone SL
Plant Mol Biol; 2018 Feb; 96(3):265-278. PubMed ID: 29270890
[TBL] [Abstract][Full Text] [Related]
6. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
7. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
Guharoy M; Bhowmick P; Tompa P
J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
[TBL] [Abstract][Full Text] [Related]
8. Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators.
Rothweiler EM; Brennan PE; Huber KVM
Biol Chem; 2022 Mar; 403(4):391-402. PubMed ID: 35191283
[TBL] [Abstract][Full Text] [Related]
9. Timer-based proteomic profiling of the ubiquitin-proteasome system reveals a substrate receptor of the GID ubiquitin ligase.
Kong KE; Fischer B; Meurer M; Kats I; Li Z; Rühle F; Barry JD; Kirrmaier D; Chevyreva V; San Luis BJ; Costanzo M; Huber W; Andrews BJ; Boone C; Knop M; Khmelinskii A
Mol Cell; 2021 Jun; 81(11):2460-2476.e11. PubMed ID: 33974913
[TBL] [Abstract][Full Text] [Related]
10. Proteasome substrate receptors and their therapeutic potential.
Osei-Amponsa V; Walters KJ
Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
[TBL] [Abstract][Full Text] [Related]
11. The San1 Ubiquitin Ligase Functions Preferentially with Ubiquitin-conjugating Enzyme Ubc1 during Protein Quality Control.
Ibarra R; Sandoval D; Fredrickson EK; Gardner RG; Kleiger G
J Biol Chem; 2016 Sep; 291(36):18778-90. PubMed ID: 27405755
[TBL] [Abstract][Full Text] [Related]
12. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
13. Assaying proteasomal degradation in a cell-free system in plants.
García-Cano E; Zaltsman A; Citovsky V
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747194
[TBL] [Abstract][Full Text] [Related]
14. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
[TBL] [Abstract][Full Text] [Related]
15. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.
Eisele F; Wolf DH
FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308
[TBL] [Abstract][Full Text] [Related]
16. Autoregulation of the 26S proteasome by in situ ubiquitination.
Jacobson AD; MacFadden A; Wu Z; Peng J; Liu CW
Mol Biol Cell; 2014 Jun; 25(12):1824-35. PubMed ID: 24743594
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin recognition by the proteasome.
Saeki Y
J Biochem; 2017 Feb; 161(2):113-124. PubMed ID: 28069863
[TBL] [Abstract][Full Text] [Related]
18. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Vriend J; Klonisch T
Cell Mol Neurobiol; 2023 May; 43(4):1425-1452. PubMed ID: 35896929
[TBL] [Abstract][Full Text] [Related]
19. ESCRT-I Component VPS23A Is Targeted by E3 Ubiquitin Ligase XBAT35 for Proteasome-Mediated Degradation in Modulating ABA Signaling.
Yu F; Cao X; Liu G; Wang Q; Xia R; Zhang X; Xie Q
Mol Plant; 2020 Nov; 13(11):1556-1569. PubMed ID: 32919085
[TBL] [Abstract][Full Text] [Related]
20. Targeted Protein Degradation through E2 Recruitment.
Forte N; Dovala D; Hesse MJ; McKenna JM; Tallarico JA; Schirle M; Nomura DK
ACS Chem Biol; 2023 Apr; 18(4):897-904. PubMed ID: 36940189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
